Smartlab Europe

The rise and rise of Global Pharma Excipients Market

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Inside Cryopreservation: Key Steps and Scientific Insights

It may sound like science fiction to the layperson,...

ICON Advarra Partnership Builds Research-Ready Trial Model

ICON, a world-leading clinical research organisation, has formalised a...

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with...
- Advertisement -

With the rise in the Global Pharma Industry, excipients too are bound to have their share of light. Of late, there has been an increasing demand for generic drugs which has, in turn, led to a rise of the excipients market. Also, there has been a steep rise in chronic disease cases as well. Not only that, but the rise in pharma excipients market can also be attributed to the Biopharmaceutical sector which has shown a lot of promise.

Global pharmaceutical excipients market is expected to reach USD 9.78 Billion by 2025, at a CAGR of 5.93% from 2018 to 2025. Europe has emerged as the largest excipient market with 41.53% market share. Presence of a substantial elderly population can be termed as one of the driving force in making this region a stronghold for excipients.

Asia too has emerged as one of the rising markets for excipients due to growth in the pharmaceutical manufacturing industry. Countries like China and India that drive the Asian pharma market are expected to give an immense push to regional CAGR which by the will be highest across the world standing at a growth of 8.09%.

Latest stories

Related stories

Inside Cryopreservation: Key Steps and Scientific Insights

It may sound like science fiction to the layperson,...

ICON Advarra Partnership Builds Research-Ready Trial Model

ICON, a world-leading clinical research organisation, has formalised a...

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with...

Egypt-Takeda Pharmaceutical Cooperation Boosts R&D Push

Egypt is stepping up its push to reinforce its...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »